(Q45025783)

8 December 2017

Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial (English)

1 reference

bronchopulmonary dysplasia

8 December 2017

1 reference

1 reference

Xavier Durrmeyer

3

0 references

Baldvin Jonsson

object named as

Baldvin Jonsson

9

0 references

Anne Greenough

object named as

Anne Greenough

7

0 references

Giovanni Vento

0 references

Manuel Sánchez Luna

1 reference

ORCID Public Data File 2021

author name string

Jean-Christophe Mercier

1

1 reference

8 December 2017

Helmut Hummler

2

1 reference

8 December 2017

Manuel Sanchez-Luna

4

1 reference

8 December 2017

Virgilio Carnielli

5

1 reference

8 December 2017

David Field

6

1 reference

8 December 2017

Bart Van Overmeire

8

1 reference

8 December 2017

Mikko Hallman

10

1 reference

8 December 2017

James Baldassarre

11

1 reference

8 December 2017

EUNO Study Group

12

1 reference

8 December 2017

language of work or name

English

0 references

publication date

23 July 2010

1 reference

8 December 2017

1 reference

8 December 2017

376

1 reference

8 December 2017

9738

1 reference

8 December 2017

346-354

1 reference

Prospects for research in reproductive health and birth outcomes

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhibition of angiogenesis decreases alveolarization in the developing rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Bronchopulmonary dysplasia: "a vascular hypothesis".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide for premature infants with severe respiratory failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide in preterm infants undergoing mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Early inhaled nitric oxide therapy in premature newborns with respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Impact of a physiologic definition on bronchopulmonary dysplasia rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

[Classification of intracranial hemorrhage in premature infants]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Racial differences in the use of respiratory medications in premature infants after discharge from the neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide for preterm infants: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960664-2

7 January 2021

10.1016/S0140-6736(10)60664-2

Identifiers

DOI

1 reference

release_iyqmxr4hardahes4kafkykgy7u

8 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iyqmxr4hardahes4kafkykgy7u

24 November 2022

mapped directly with Wikidata item

1 reference